June 17, 2013
BANGALORE, IndiaSALCITAL by Olive Lifesciences may benefit pre-diabetes management and mild to moderate hyperlipidemia, according to a study published in the Journal of Medicinal Food (June 2013, 16(6): 564-568. DOI:10.1089/jmf.2013.2751).
The randomized, double blind, placebo-controlled study evaluated the efficacy and safety of Salacia leaves and root bark extracts in 29 subjects with pre-diabetes and mild to moderate hyperlipidemia. Subjects received either Salacia extracts or placebos, along with therapeutic lifestyle changes, for a period of six weeks. Researchers observed a significant reduction in low-density lipoprotein (LDL) cholesterol and fasting blood sugar (FBS) levels at weeks three and six in patients treated with root bark extract. The leaves extract-treated group showed statistically significant reduction in FBS levels at week six only.
Apart from its nutraceutical application, SALCITAL is also applicable as dry drink mixes, ready-to-drink (RTD) products, nutritional bars and other beverages, according to C.A. Anzar, managing director of Olive Lifesciences.
You May Also Like